Document is current
Any future updates will be listed below
-
Authors
Wang, Joy Y.
Tuck, Owen T. http://orcid.org/0000-0002-0348-6910
Skopintsev, Petr
Soczek, Katarzyna M. http://orcid.org/0000-0003-3803-6079
Li, Gary
Al-Shayeb, Basem
Zhou, Julia
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
- License Information
-
More Information
Article History
Received: 26 January 2023
Accepted: 8 May 2023
First Online: 14 June 2023
Competing interests
: The Regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D. is an inventor. J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics, and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Vertex, Caribou Biosciences, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Algen Biotechnologies, Felix Biosciences, The Column Group and Inari. J.A.D. is Chief Science Advisor to Sixth Street, a Director at Johnson & Johnson, Altos and Tempus, and has research projects sponsored by Apple Tree Partners and Roche.
